TY  - GEN
AU  - Seldin,D C
AU  - Andrea,N
AU  - Berenbaum,I
AU  - Berk,J L
AU  - Connors,L
AU  - Dember,L M
AU  - Doros,G
AU  - Fennessey,S
AU  - Finn,K
AU  - Girnius,S
AU  - Lerner,A
AU  - Libbey,C
AU  - Meier-Ewert,H K
AU  - O'Connell,R
AU  - O'Hara,C
AU  - Quillen,K
AU  - Ruberg,F L
AU  - Sam,F
AU  - Segal,A
AU  - Shelton,A
AU  - Skinner,M
AU  - Sloan,J M
AU  - Wiesman,J F
AU  - Sanchorawala,V
TI  - High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution
SN  - 1744-2818
PY  - 2011///1115
KW  - Amyloidosis
KW  - drug therapy
KW  - Combined Modality Therapy
KW  - Dose-Response Relationship, Drug
KW  - Humans
KW  - Immunoglobulin Light Chains
KW  - Stem Cell Transplantation
KW  - Survival Rate
KW  - Transplantation, Autologous
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.3109/13506129.2011.574354047
ER  -